Brokerages Set LeMaitre Vascular Inc (NASDAQ:LMAT) Target Price at $40.00
Shares of LeMaitre Vascular Inc (NASDAQ:LMAT) have earned an average rating of “Buy” from the seven ratings firms that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $40.00.
Several equities research analysts have recently commented on the company. ValuEngine cut LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Monday, October 7th. Lake Street Capital raised LeMaitre Vascular from a “hold” rating to a “buy” rating and set a $40.00 target price for the company in a research note on ...